MARKSANS PHARMA
|
MARKSANS PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹504 Cr | ₹424 Cr | ₹338 Cr | ₹248 Cr | ₹302 Cr |
| Adjustment | ₹69 Cr | ₹55 Cr | ₹74 Cr | ₹35 Cr | ₹57 Cr |
| Changes In working Capital | ₹-241 Cr | ₹-126 Cr | ₹-111 Cr | ₹-111 Cr | ₹-132 Cr |
| Cash Flow after changes in Working Capital | ₹333 Cr | ₹353 Cr | ₹300 Cr | ₹172 Cr | ₹227 Cr |
| Cash Flow from Operating Activities | ₹207 Cr | ₹230 Cr | ₹237 Cr | ₹99 Cr | ₹179 Cr |
| Cash Flow from Investing Activities | ₹-49 Cr | ₹-141 Cr | ₹-259 Cr | ₹-84 Cr | ₹-45 Cr |
| Cash Flow from Financing Activities | ₹-65 Cr | ₹-69 Cr | ₹198 Cr | ₹80 Cr | ₹-15 Cr |
| Net Cash Inflow / Outflow | ₹93 Cr | ₹21 Cr | ₹176 Cr | ₹94 Cr | ₹118 Cr |
| Opening Cash & Cash Equivalents | ₹403 Cr | ₹382 Cr | ₹206 Cr | ₹112 Cr | ₹94 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | ₹0.00 Cr | - | - |
| Closing Cash & Cash Equivalent | ₹496 Cr | ₹403 Cr | ₹382 Cr | ₹206 Cr | ₹212 Cr |
Compare Cashflow Statement of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹8,017.1 Cr | -0% | 3.2% | -35.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,791.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,885.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,930.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,108.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,164.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -0% |
3.2% |
-35.1% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses